Given the reciprocal activity of BRD4 with the YAP/TAZ complex, dual BRD4 and YAP/TAZ inhibition could potentially enhance therapeutic efficacy with respect to mechanosignaling‐associated properties of tumour cells. This evidence concerns the gene BRD4 and neoplasm.